MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-25-2025
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.29 B |
Market Cap[1] |
$ 124 B |
EBITDA (LTM) |
$ 8.08 B |
P/E (LTM) |
25.07 |
P/S (LTM) |
3.65 |
EPS (LTM) |
3.88 |
Medtronic is an international medical company that specializes in developing and manufacturing innovative medical technologies. The company was founded in the United States in 1949 and today is a leader in the field of medical technology.
Medtronic offers a wide range of products and services in cardiology, endocrinology, neurology, orthopedics, surgery, and more. Among the company's products are implantable cardiac pacemakers, glucose meters, insulin infusion pumps, pain management systems, deep brain stimulation devices, and much more.
Medtronic is actively engaged in scientific research and development in the field of medicine. As a result, its products are the most effective and safe for patients. The company also provides training and consultations to doctors and medical personnel on the use of its products.
Medtronic has offices and representatives in more than 160 countries around the world, which allows it to provide maximum accessibility of its products and services to patients worldwide. Medtronic is a reliable partner for medical institutions and patients who need innovative solutions to maintain health and life.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Apyx Medical Corporation
APYX
|
$ 3.47 | -3.61 % | $ 120 M | Nasdaq Global Select Market | USA |
 |
Boston Scientific Corporation
BSX
|
$ 96.06 | -0.04 % | $ 141 B | NYSE,SPB | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Cognyte Software Ltd.
CGNT
|
$ 9.35 | -1.99 % | $ 671 M | Nasdaq Global Select Market,SPB |  Israel |
 |
Bio-Rad Laboratories
BIO
|
$ 303.76 | 0.52 % | $ 8.57 B | NYSE,SPB | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
Bruker Corporation
BRKR
|
$ 47.89 | -0.48 % | $ 7.14 K | Nasdaq Global Select Market,SPB | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
Abbott Laboratories
ABT
|
$ 124.72 | -0.1 % | $ 217 B | NYSE,SPB | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 3.3 | 11.09 % | $ 123 M | Nasdaq Global Market |  France |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | Israel |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
InMode Ltd.
INMD
|
$ 14.62 | 1.04 % | $ 1.16 B | Nasdaq Global Select Market,SPB | Israel |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.21 | 6.14 % | $ 19.5 M | Nasdaq Global Select Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
LivaNova PLC
LIVN
|
$ 62.92 | -0.25 % | $ 3.41 B | Nasdaq Global Select Market |  Britain |
 |
Align Technology
ALGN
|
$ 158.62 | 0.49 % | $ 11.9 B | Nasdaq Global Select Market,SPB | USA |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
Accuray Incorporated
ARAY
|
$ 0.83 | -3.49 % | $ 85.3 M | Nasdaq Global Select Market | USA |
|
LENSAR
LNSR
|
$ 12.03 | 0.17 % | $ 139 M | Nasdaq Capital Market | USA |
 |
IRadimed Corporation
IRMD
|
$ 97.53 | 0.48 % | $ 1.24 B | Nasdaq Global Select Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
ClearPoint Neuro
CLPT
|
$ 14.04 | -3.13 % | $ 379 M | Nasdaq Capital Market | USA |
 |
FONAR Corporation
FONR
|
$ 14.51 | -0.13 % | $ 95.1 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 32.87 | 0.7 % | $ 1.45 B | Nasdaq Capital Market,SPB | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
CONMED Corporation
CNMD
|
$ 40.89 | 2.12 % | $ 1.26 B | NYSE,SPB | USA |
 |
OrthoPediatrics Corp.
KIDS
|
$ 17.36 | -0.29 % | $ 401 M | Nasdaq Global Select Market,SPB | USA |
 |
Globus Medical
GMED
|
$ 88.38 | -0.15 % | $ 12 B | NYSE,SPB | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 12.65 | -0.08 % | $ 974 M | Nasdaq Global Select Market,SPB | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Aethlon Medical
AEMD
|
$ 2.58 | 3.61 % | $ 4.03 M | Nasdaq Capital Market | USA |
 |
Myomo
MYO
|
$ 1.02 | - | $ 7.19 M | NYSE American | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.